Table I.

Clinicopathological parameters of TNBC patients (total cases, n=55).

		miR-182 expression
Characteristics	Cases	Low, n (%)	High, n (%)	P-value
Age (years)				0.7048
≤40	9	2 (22.22)	7 (77.78)
>40	46	15 (32.61)	31 (67.39)
Tumor size (cm)				0.7230
<2	10	3 (30.00)	7 (70.00)
≥2	45	19 (42.22)	26 (57.78)
Lymph node metastases				0.0431
0	3	1 (33.33)	2 (66.67)
1–3	10	5 (50.00)	5 (50.00)
>3	42	6 (14.29)	36 (85.71)
Differentiation				0.2788
Well	5	2 (40.00)	3 (60.00)
Moderate	10	5 (50.00)	5 (50.00)
Poor	40	12 (30.00)	28 (70.00)
Tumor stage				0.0216
I+II	16	7 (43.75)	9 (56.25)
III+IV	39	5 (12.82)	34 (87.18)

TNBC, triple-negative breast cancer.